Evaluation of intravenous and oral use of metrazol in hospitalized arteriosclerotic psychiatric patients.
D000368:Aged; D001161:Arteriosclerosis; D003704:Dementia; D004194:Disease; D006801:Humans; D001523:Mental Disorders; D010433:Pentylenetetrazole / Q000627:therapeutic use*; D011618:Psychotic Disorders
D010433:Pentylenetetrazole
AGED/diseases; ARTERIOSCLEROSIS; PENTYLENETETRAZOLE/therapeutic use; PSYCHOSES, SENILE